Search Results - "Fumero, E"

Time to relapse after tildrakizumab withdrawal in patients with moderate‐to‐severe psoriasis who were responders at week 28: post hoc analysis through 64 weeks from reSURFACE 1 trial by Warren, R.B., Carrascosa, J.M., Fumero, E., Schoenenberger, A., Lebwohl, M.G., Szepietowski, J.C., Reich, K.

“…Background As treatment interruptions occur during psoriasis management in clinical practice, it is important to know the duration of clinical response after…”
Get full text

New patterns of HIV-1 resistance during HAART by Fumero, E., Podzamczer, D.

“…HIV-1 resistance and subsequent virologic failure occur in a substantial proportion of HIV-infected patients receiving HAART regimens. In the present article,…”
Get full text

MN1–Fli1 oncofusion transforms murine hematopoietic progenitor cells into acute megakaryoblastic leukemia cells by Wenge, D V, Felipe-Fumero, E, Angenendt, L, Schliemann, C, Schmidt, E, Schmidt, L H, Thiede, C, Ehninger, G, Berdel, W E, Arteaga, M-F, Mikesch, J-H

“…Long-term outcome of acute megakaryoblastic leukemia (AMKL) patients without Down’s syndrome remains poor. Founding mutations and chimeric oncogenes…”
Get full text

Retinopatía MEK. Casos clínicos by Rocha Cabrera, P, Quijada Fumero, E, Losada Castillo, M.J, Abreu Reyes, J.A, Lorenzo Morales, J

“…Resumen Casos clínicos Se presentan 3 casos clínicos de retinopatía MEK asociados al uso de la combinación de cobimetinib y vemurafenib, caracterizados por la…”
Get full text

MEK Retinopathy. Clinical case reports by Rocha Cabrera, P, Quijada Fumero, E, Losada Castillo, M.J, Abreu Reyes, J.A, Lorenzo Morales, J

“…Abstract Case reports Three clinical cases are presented of MEK retinopathy associated with the combination of cobimetinib and vemurafenib characterized by…”
Get full text

Risk of Selecting De Novo Drug-Resistance Mutations during Structured Treatment Interruptions in Patients with Chronic HIV Infection by Arnedo-Valero, M., García, F., Gil, C., Guila, T., Fumero, E., Castro, P., Blanco, J. L., Miró, J. M., Pumarola, T., Gatell, J. M.

“…Background. Structured treatment interruption (STI) may allow viral replication in the presence of decreased plasma drug levels, with risk of selection of…”
Get full text

A cost-effectiveness study of dexamethasone implants in macular edema by Lozano López, V, Serrano García, M, Mantolán Sarmiento, C, Pareja Ríos, A, Losada Castillo, M.J, Cordovés Dorta, L, Quijada Fumero, E, Virgós Aller, T, Bullejos Molina, M

“…Abstract Objective To analyse the cost-effectiveness and benefits of a dexamethasone intravitreal implant (Ozurdex® , Allergan, Irvine, CA, USA) in its…”
Get full text

Transmission of Hepatitis C Virus by Discarded-Needle Injury by Libois, Agnès, Fumero, Emilio, Castro, Pedro, Nomdedeu, Meritxell, Cruceta, Anna, Gatell, José Maria, Garcia, Felipe

Get full text

The role of nevirapine in the treatment of HIV-1 disease by Podzamczer, D, Fumero, E

“…Nevirapine (Viramune, Boehringer Ingelheim) is a non-nucleoside reverse transcriptase (RT) inhibitor (NNRTI) effective in the treatment of HIV-1 infected…”
Get more information

Immunosuppressive drugs as an adjuvant to HIV treatment by Fumero, Emilio, García, Felipe, Gatell, J. M.

“…Although highly active antiretroviral therapy (HAART) has dramatically changed the epidemiological impact of HIV infection, many problems with currently used…”
Get full text

Geometry package for Monte Carlo simulations on CAD files by Borglund, N, Eriksson, J, Fumero, E, Kjäll, P, Mårtensson, L, Orsholm, C, Sikora, T

“…A computer-code package handling geometry descriptions exported from Computer-Aided Design (CAD) applications has been developed for use in Monte Carlo (MC)…”
Get full text

465 Tirbanibulin, a novel anti-proliferative and pro-apoptotic agent for the treatment of actinic keratosis by Pitzonka, L., Cutler, M., Bu, Y., Blanco, A., Fumero, E., Torra, A., Smolinski, M.

Get full text

Resultados coste-efectividad del implante de dexametasona en edema macular by Lozano López, V, Serrano García, M, Mantolán Sarmiento, C, Pareja Ríos, A, Losada Castillo, M.J, Cordovés Dorta, L, Quijada Fumero, E, Virgós Aller, T, Bullejos Molina, M

“…Resumen Objetivo Analizar el beneficio coste-efectividad del implante intravítreo de dexametasona (Ozurdex® , Allergan, Irvine, CA, EE. UU.) en sus…”
Get full text

Digital pulse-shape processing for CdTe detectors by Bargholtz, Chr, Fumero, E., Mårtensson, L., Wachtmeister, S.

“…CdTe detectors suffer from low photo-peak efficiency and poor energy resolution. These problems are due to the drift properties of charge carriers in CdTe…”
Get full text

LB918 Tirbanibulin, a novel inhibitor of tubulin polymerisation and src kinase signaling, for actinic keratosis (AK): Results of two phase-3 studies and 1-year follow-up data by Blauvelt, A., Kempers, S., Puig, S., Martin, G., Fumero, E., Grada, A., Cutler, D., Fang, J.

Get full text

Long-term Clinical Follow-up, without Antiretroviral Therapy, of Patients with Chronic HIV-1 Infection with Good Virological Response to Structured Treatment Interruption by Florence, Eric, García, Felipe, Plana, Montserrat, Fumero, Emilio, Castro, Pedro, Lopez, Anna, Cruceta, Anna, Gil, Cristina, Arnedo, Mireia, Miró, José M., Pumarola, Tomás, Gallart, Teresa, Gatell, José M.

“…The present study assessed the long-term clinical follow-up of 26 of 60 human immunodeficiency virus (HIV)—positive patients who followed structured treatment…”
Get full text

224 Profiling the effects of acne therapeutics, including the novel narrow-spectrum antibiotic sarecycline, on the human microbiota by Moura, I., Spittal, W., Clark, E., Ewin, D., Altringham, J., Fumero, E., Grada, A., Wilcox, M., Buckley, A.

Get full text

Model-based pulse shape correction for CdTe detectors by Bargholtz, Chr, Fumero, E, Mårtensson, L

“…We present a systematic method to improve energy resolution of CdTe-detector systems with full control of the efficiency. Sampled pulses and multiple amplifier…”
Get full text

Nepafenaco para edema macular cistoideo secundario a paclitaxel by Tapia Quijada, H.E., Quijada Fumero, E., Mesa Lugo, F.I., Serrano García, M., Betancor Caro, N.

“…El paclitaxel es utilizado para tratar una amplia gama de tumores malignos. Se sabe que estos fármacos causan efectos adversos oculares, siendo el edema…”
Get full text

Nepafenac for cystoid macular oedema secondary to paclitaxel by Tapia Quijada, H.E., Quijada Fumero, E., Mesa Lugo, F.I., Serrano García, M., Betancor Caro, N.

“…Paclitaxel is used to treat a wide range of malignant tumours. This type of drug is known to cause ocular adverse effects, with cystoid macular oedema being a…”
Get full text